Anodic Titanium Dioxide Nanotubes for Magnetically Guided Therapeutic Delivery

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Hollow titanium dioxide (TiO2) nanotubes offer superior drug loading and controlled release compared to solid nanocarriers.
• Iron oxide nanoparticles can enable magnetic targeting for site-specific drug delivery.

Purpose of the Study:

• To develop magnetic TiO2 nanotubes (TiO2NTs) for enhanced drug delivery.
• To evaluate the biocompatibility, cellular interaction, and therapeutic efficacy of these magnetic nanocarriers.

Main Methods:

• Incorporation of iron oxide nanoparticles into TiO2 nanotube structures.
• Thermal annealing and sonication for nanotube separation.
• In vitro assessment of cytotoxicity, cellular adhesion, and endocytosis in HeLa cells.
• Loading with camptothecin (drug) and oligonucleotides (for transfection) to demonstrate therapeutic potential.

Main Results:

• Magnetic TiO2NTs are non-toxic to HeLa cells at therapeutic concentrations (≤200 µg/mL).
• Magnetic field enhances nanotube adhesion and cellular endocytosis.
• Achieved 90% killing efficiency with camptothecin and 100% cellular uptake with oligonucleotides.

Conclusions:

• Magnetic TiO2NTs are a promising platform for site-specific drug and therapeutic agent delivery.
• The enhanced cellular interaction and efficacy highlight their potential in various biomedical applications.